Original Contribution
Amoxicillin-Clavulanate vs Ciprofloxacin for the Treatment of Uncomplicated Cystitis in Women
(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.
Figure 2. Time to Persistent or Recurrent UTI by Treatment Group and Amoxicillin-Clavulanate Susceptibility of Infecting Strain at Enrollment
A, P<.001. B, P = .004 for the comparison of ciprofloxacin vs amoxicillin-clavulanate (susceptible); P = .17 for the comparison of amoxicillin-clavulanate (susceptible) vs amoxicillin-clavulanate (nonsusceptible). UTI indicates urinary tract infection.
CiteULike
Connotea
Delicious
Digg
Facebook
Reddit
Technorati
Twitter
This Article
-
JAMA. 2005;293(8):949-955. doi: 10.1001/jama.293.8.949
Current Issue
Information For
JAMA & Archives Journals
Most
-
Viewed
- Prevalence of Obesity and Trends in the Distribution of Body Mass Index Among US Adults, 1999-2010
- Effect of Dietary Protein Content on Weight Gain, Energy Expenditure, and Body Composition During Overeating: A Randomized Controlled Trial
- Prevalence of Oral HPV Infection in the United States, 2009-2010
- Weight Loss Strategies for Adolescents: A 14-Year-Old Struggling to Lose Weight
- Prevalence of Obesity and Trends in Body Mass Index Among US Children and Adolescents, 1999-2010
-
Cited
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
- The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
- Prevalence of Overweight and Obesity in the United States, 1999-2004
JAMA Clinical Challenge
